Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

891362

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with representatives of the Australian government on proposals for the Universal Cancer Databank.
tabling member constituency	Belfast North
tabling member printed	Nigel Dodds
uin	137964
answer	answer is ministerial correction date of answer 01/05/2018 answer text <p>The Government has not engaged in direct discussions with representatives of the Australian Government on proposals for a Universal Cancer Databank. The Department has however engaged closely with the Eliminate Cancer Initiative on this matter, who have engaged directly with the Australian Government.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/05/2018 14:24:56 answering member 4067 label Biography information for Steve Brine
tabling member	1388 label Biography information for Lord Dodds of Duncairn

891363

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Motor Neurone Disease: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress has been made on the development of treatments for motor neurone disease.
tabling member constituency	Belfast North
tabling member printed	Nigel Dodds
uin	137965
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>Treatment for motor neurone disease (MND) can include a range of approaches such as counselling and emotional support, respiratory care, speech and language therapy, physiotherapy, respiratory secretion management, neurorehabilitation, physiotherapy and palliative care. Whilst drugs can be used for symptom management, riluzole is the only pharmacological drug licensed in the United Kingdom to slow the progression of MND.</p><p><br> Through the National Institute for Health Research (NIHR), we are investing over £1 billion a year in health research. In 2016-17, the NIHR invested £4.58 million to fund and support a range of research studies and infrastructure with a focus on MND and closely-related conditions. Current research falls in to three broad categories:</p><p>- Drugs that will slow down or cure MND;</p><p>- Improving care, symptom management and quality of life for people with MND; and</p><p>- Work to better categorise patients with MND so that treatments can be personalised.</p><p>Examples of drug research include the first gene therapy studies for a type of MND that runs in families, and a multicentre academic European Union and MND Association funded study of interleukin-2 to assess whether it can slow progression by reducing the immune system response.</p><p><br> <br> The NIHR welcomes funding applications for research into any aspect of human health, including MND. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>The Medicines and Healthcare products Regulatory Authority has also advised that it is aware of five active clinical trials into treatments for MND.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/05/2018 13:19:20 answering member 4067 label Biography information for Steve Brine
tabling member	1388 label Biography information for Lord Dodds of Duncairn

891378

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cerebral Palsy: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make available on the NHS, Selective Dorsal Rhizotomy procedures to reduce spasticity in lower limbs; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	137896
answer	answer is ministerial correction date of answer 30/04/2018 answer text <p>NHS England does not currently routinely commission Selective Dorsal Rhizotomy surgery and published a policy in 2014 based on the clinical evidence available at that time, which did not demonstrate the benefits of surgery over and above other non-surgical treatment options (such as intensive physiotherapy).</p><p> </p><p>However, given the continued clinical and patient interest in the procedure, NHS England invested in a Commissioning through Evaluation (CtE) scheme which has gathered new ‘real world’ evidence from 140 children undergoing surgery in selected centres in England. The interim results of this scheme, independently evaluated by the National Institute for Health and Care Excellence, together with an updated review of the published evidence of clinical effectiveness, have been used to support the drafting of an updated policy proposition which will be considered as part of NHS England’s relative prioritisation process for investments in specialised care in May 2018.</p><p> </p><p>If appropriate, there may also be an opportunity to further review the policy once the full evaluation is available from the CtE scheme in autumn 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/04/2018 13:18:02 answering member 4067 label Biography information for Steve Brine
tabling member	253 label Biography information for Mr Laurence Robertson

891381

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gambling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of people who have received counselling or other treatment for an addiction to gambling in the last six months.
tabling member constituency	West Bromwich East
tabling member printed	Tom Watson
uin	137977
answer	answer is ministerial correction date of answer 30/04/2018 answer text <p>Information on the number of people who have received counselling or treatment for an addiction to gambling is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/04/2018 13:11:51 answering member 4067 label Biography information for Steve Brine
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

891382

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gambling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of people who have a gambling addiction.
tabling member constituency	West Bromwich East
tabling member printed	Tom Watson
uin	137978
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>Estimates of the numbers of people who are problem gamblers are not readily available, but the Health Survey for England does provide percentage prevalence rates. In 2016, 0.7% of people in England were identified as problem gamblers.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/05/2018 13:28:27 answering member 4067 label Biography information for Steve Brine
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

891440

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	GP at Hand
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients are registered with the GP at Hand service.
tabling member constituency	Leigh
tabling member printed	Jo Platt
uin	138110
answer	answer is ministerial correction date of answer 30/04/2018 answer text <p>The Lille Road Health Centre, which is the practice all patients registered with the GP at Hand service are associated with, has a registered list of 24,652 as of March 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/04/2018 13:21:49 answering member 4067 label Biography information for Steve Brine
tabling member	4673 label Biography information for Jo Platt

891454

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Health Care: Internet
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking in response to the Care Quality Commission report, The state of care in independent online primary health services.
tabling member constituency	East Yorkshire
tabling member printed	Sir Greg Knight
uin	137959
answer	answer is ministerial correction date of answer 30/04/2018 answer text <p>The Department is working with the Care Quality Commission to consider what further action is needed following this report, to ensure we are striking a balance between the provision of safe, effective and high-quality care whilst not stifling innovation.</p><p> </p><p>A cross-regulatory forum has been set up to consider the issues online providers pose for the regulatory model. In addition, NHS England’s clinical safety group will review the recommendations in the report and determine further action for current online services.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/04/2018 13:23:42 answering member 4067 label Biography information for Steve Brine
tabling member	1200 label Biography information for Sir Greg Knight

891471

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Muscular Dystrophy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the suitability of the Single Technology Appraisal process for new treatments for patients with Duchenne Muscular Dystrophy.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	137885
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources.</p><p> </p><p>NICE assesses most significant new drugs through its technology appraisal programme and has been able to recommend a number of drugs licenced for the treatment of rare diseases for routine use on the NHS. NICE also operates a separate highly specialised technology (HST) evaluation programme for the assessment of very high cost drugs for the treatment of very small numbers of patients. Decisions on the most appropriate programme for individual drugs and other treatments are made through an established topic selection process that includes a public consultation and thorough consideration against a set of published criteria.</p><p> </p><p>NICE published HST guidance recommending ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene in July 2016 and is currently developing guidance, through its technology appraisal and HST programmes, on other drugs for the treatment of Duchenne muscular dystrophy.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/05/2018 15:58:20 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

891478

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increasing flexibility within NICE's Single Technology Appraisal process for medicines for rare diseases.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	137886
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>The Department has made no such assessment. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the NHS on whether drugs and other treatments represent an effective use of National Health Service resources.</p><p> </p><p>NICE assesses most significant new drugs through its technology appraisal programme and has been able to recommend a number of drugs licenced for the treatment of rare diseases for routine use on the NHS. NICE also operates a separate highly specialised technology evaluation programme for the assessment of very high cost drugs for the treatment of very small numbers of patients.</p><p> </p><p>NICE’s methods and processes for the assessment of drugs have been carefully developed over time and are internationally respected. NICE continues to keep its procedures under periodic review to ensure that they remain effective.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/05/2018 13:21:07 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

891503

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Asians
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the prevalence of (a) type 1 and (b) type 2 diabetes is amongst people of South Asian origin, in (i) each parliamentary constituency, (ii) each clinical commissioning group, and (iii) in England, in the most recent year for which data is available.
tabling member constituency	Shipley
tabling member printed	Philip Davies
uin	138010
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>Data on the prevalence of type 1 and type 2 diabetes among people of South Asian origin, in each parliamentary constituency, each clinical commissioning group, and in England, are not published in the format requested.</p><p> </p><p>The National Diabetes Audit (NDA) reports that approximately 8% of those with type 1 diabetes are from a minority ethnic origin and approximately 19% of those with type 2 diabetes are from a minority ethnic origin.</p><p> </p><p>The NDA records the ethnicity of diabetes patients (and other patient characteristics). Information on ethnicity is split by White/ Minority Ethnic Origin and Unknown. Minority ethnic origin includes South Asian, Chinese and other Asian, black, mixed and other ethnicities. The NDA routinely monitors the effects of ethnicity on patient outcomes, percentage of patients receiving National Institute for Health and Care Excellence’s (NICE’s) recommended eight care processes; achievement of NICE treatment targets and diabetic complications. Further information is available at the following link:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/national-diabetes-audit-report-1-findings-and-recommendations-2016-17" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/national-diabetes-audit-report-1-findings-and-recommendations-2016-17</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 138011 question first answered 03/05/2018 13:26:07 answering member 4067 label Biography information for Steve Brine
tabling member	1565 label Biography information for Sir Philip Davies